This negative regulation of TILs by melanoma loss of the IFN-γ signaling, together with the reduced sensitivity of IFNγR1KO melanoma cells to IFN-γ-mediated tumor killing, poses a dual resistance to ICBs. Here, IFNG is linked to melanoma.